Table 2: Patient characteristics and treatments received before initiation of ketogenic diet.

Patient Age Sex Diagnosis EEG Previously epilepsy history Duration of SE before KD (days) Number of AEDs before SE Steroid or ACTH before KD IVIG before KD
1 3 Female LGS Gen. SE Yes 11
LEV,
VPA,
PHT,
CZP,
CLB,
PB,
TPN,
MDZ
Yes No
2 2 Female Cerebral palsy, refractory epilepsy Focal SE Yes 20 6
LEV,
VPA,
PHT,
CBZ,
CLB,
PB,
TPN,
MDZ
No Yes
3 3 Female LGS Gen. SE Yes 15 6
LEV,
VPA,
PHT,
TPM,
PB,
TPN
No Yes
4 9 Female Epileptic encephalopathy (of unknown cause, unclassifiable) Jen. SE Yes 13 8
LEV,
VPA,
PHT,
CLB,
PB,
TPN,
MDZ,
PPF
Yes Yes
5 5 Male HSV encephalitis Focal SE No 12 5
LEV,
VPA,
PHT,
CBZ,
TPN
No No
6 1 Male Epileptic encephalopathy (WOXX mutation) Jen. SE Yes 8 4
LEV,
PHT,
PB,
TPN
No No

AED: Antiepileptic Drug; CBZ: Carbamazepine; CLB: Clobazam; CZP: Clonazepam; EEG: Electroencephalography; Focal SE: Focal Status Epilepticus; Gen. SE: Generalized Status Epilepticus; HSV: Herpes Simplex Virus; IVIG: Intravenous Immunoglobulin; KD: Ketogenic Diet; LGS: Lennox-Gastaut Syndrome; LEV: Levetiracetam; MDZ: Midazolam; PHT: Phenytoin; PB: Phenobarbital; TPN: Thiopental; TPM: Topiramate; VPA: Valproic Acid.